TrialLeukemia2026

Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia.

Michela Ansuinelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.